Articles tagged with Spinal Cord
Kessler Foundation and collaborators win $1 million prize for proof-of-concept study on tablet-type controller StimXS, designed to help individuals with spinal cord injuries manage autonomic functions. The team advances to Phase 3 of the NIH Common Fund's Neuromod Prize competition.
Scientists at Karolinska Institutet and Stockholm University have mapped the cellular architecture of MS lesions using advanced methodology. This reveals how immune cells and glial cells interact in the disease.
Researchers have developed a new dural repair solution using a multi-functional biomaterial that addresses key limitations of current methods. The 'Dural Tough Adhesive' (DTA) performed better than currently used surgical sealants in tests using animal models and human-derived tissues.
Scientists have developed fUSI technology that enables clinicians to see and map the spinal cord's response to treatments in real-time. This innovation offers improved monitoring of blood flow changes, potentially increasing treatment success rates and optimizing pain relief for patients.
Researchers found that 86 patients experienced severe residual paresthesia after spinal surgery, leading to lower satisfaction rates. Patients with pre-surgical pain were more likely to have persistent paresthesia, highlighting the need for treatment strategies for this condition.
Scientists have pinpointed the group of neurons in the nerve cord that produce and pattern the fly's two major courtship songs. By analyzing neuronal activity and connectivity, researchers found a small number of critical neurons form a highly connected circuit generating the two main types of songs.
Researchers at the University of Cincinnati's Lindner Center of HOPE have developed a novel approach to treating depression using spinal cord stimulation. The study found that electrical stimulation of the spinal cord decreased depressive symptoms and showed therapeutic potential.
Researchers found that the severity of muscle wasting depends on the location of the spinal cord injury. They also discovered that hypercortisolism, a hormonal imbalance, worsens muscle loss and can be targeted to rescue muscle tissue.
Researchers have developed a spinal cord stimulation technology that restores sensation, improves function, and reduces phantom limb pain after trans-tibial amputation. The study showed significant improvements in balance control and gait stability, with an average 70% reduction in phantom limb pain.
Researchers at Ohio State University Wexner Medical Center are testing a novel diagnosis and treatment combination for painful diabetic neuropathy using spinal cord stimulation and small fiber nerve activity measurement. The approach has the potential to provide effective pain relief and potentially reverse neuropathy reversal.
Researchers have identified a conserved brain region in vertebrates essential for initiating forward movement. The mesencephalic locomotor region (MLR) stimulates reticulospinal neurons to control finer details of movement. Mapping this circuit could lead to new treatments for Parkinson's disease.
Researchers at CityU and HKUMed developed genetically modified human neural stem cells that promote neural circuit reconstruction, reduce glial scar accumulation, and enhance axon outgrowth. The therapy demonstrates potential for treating severe spinal cord injuries with functional recovery.
The USC NRV Center performs complex revascularization procedures and conducts innovative research to treat debilitating conditions. The center will use the funding to enhance clinical care and education with a focus on technological innovation.
Rice University scientists have developed a tiny, flexible spinal probe system that can record high-quality data from spinal cord neurons and provide localized stimulation. The new tool aims to improve our understanding of spinal cord function and potentially bring new hope to patients with injuries or conditions.
Researchers used mouse genetics to determine if brain or spinal cord causes dystonia, finding that spinal cord is responsible. Spinal cord dysfunction leads to signs of dystonia similar to those seen in humans, providing a new target for treatment.
A team of researchers found that a small population of nerve cells exists in everyone that could be coaxed to regrow, potentially restoring sight and movement. The discovery provides new insights into how axons grow and could lead to effective therapies for blindness, paralysis, and other disorders caused by nerve damage.
A new study published in Science Advances has found that certain antibodies against the Epstein-Barr virus can mistakenly target the brain and spinal cord, causing damage in multiple sclerosis patients. The research reveals a potential link between EBV infection and MS, with implications for personalized therapies.
A mobile app called SCI Step Together encourages people with partial spinal cord injuries to get active by setting goals, tracking activities, and connecting with others. The study found that participants who used the app had greater fulfillment of basic psychological needs, including independence, competence, and belonging.
The gene LRRC4 regulates synapse formation, stability and excitatory transmission, playing a crucial role in learning, memory formation and storage. It also has key implications in neuronal disorders and aggressive brain and spinal cord cancer.
Researchers uncover a pathophysiological mechanism that initiates and sustains neuropathic pain in mice, identifying Tiam1 as a potential therapeutic target. Targeting spinal Tiam1 with antisense oligonucleotides alleviates neuropathic pain hypersensitivity, offering promise for treating chronic pain.
Researchers found that spinal cord stimulation reduced pain response in rats with human lung cancer tissue without compromising paclitaxel effectiveness. The study also showed SCS improved antitumor efficacy of paclitaxel, providing evidence for its potential as a companion treatment.
Scientists have created a detailed map of human spinal cord cell formation, shedding light on how injuries and diseases arise. The study's findings hold promise for developing new therapies for spinal cord injuries and diseases like ALS.
Cedars-Sinai investigators have discovered a novel way to treat amyotrophic lateral sclerosis (ALS) and retinitis pigmentosa using human induced pluripotent stem cells. The new approach uses cells derived from iPSCs that are renewable, scalable, and can delay disease progression in rodents.
Researchers at Salk Institute discover that mechanical and chemical itch sensations are encoded by different brain pathways, which act together to drive chronic itch. The study reveals key molecules regulating these pathways and opens avenues for new therapies.
WVU engineers developed a new electrode cuff called MouseFlex to test electric current treatments, overcoming previous challenges with stability and durability. The device can withstand high electrical stimulation and may benefit patients with conditions like rheumatoid arthritis and drug-resistant epilepsy.
Researchers aim to assess the effectiveness of spinal cord transcutaneous stimulation and a cognitive training program in improving processing speed abilities and upper extremity function after spinal cord injury. The studies will test innovative approaches to enhance rehabilitation outcomes for individuals with spinal cord injuries.
Researchers at Nagoya University found that localized IDH wild-type histologically diffuse astrocytomas have a poor prognosis similar to the most malignant types of brain and spinal cord tumors. This highlights the importance of proper clinical diagnosis and treatment for patients with gliomas.
Researchers have created wearable microscopes to produce high-definition, real-time images of mouse spinal cord activity across previously inaccessible regions. This technology enables unprecedented insight into the neural basis of sensations and movement in healthy and disease contexts.
Researchers have found a possible new target for therapies aimed at treating age-related neurological diseases by linking increased presence of immune cells to conditions like Alzheimer's disease. Microglia, specialized immune cells in the brain, can adopt a dysfunctional state that contributes to neurodegenerative diseases.
A new review found that spinal cord stimulation is no better than a placebo for treating low back pain, with probably little to no benefit for people with the condition. The review also highlighted gaps in clinical data and called for future trials to be longer and more comprehensive.
A study found that high-frequency spinal cord stimulation significantly reduced average pain levels by 76%, while improving motor function and sensation. The therapy's long-term safety and potential disease-modifying effects are promising, but further studies are needed to confirm the results.
Recreational nitrous oxide use can lead to subacute combined degeneration of the spinal cord, causing serious disability in young people. The new guidelines provide practical solutions for early recognition and effective treatment to alleviate pressure on hospitals.
A research team at Chinese Academy of Sciences creates a spinal cord-like implant with covalent conjugation between biomaterials and cells, promoting cell retention and neural regeneration in rats after spinal cord injury. The study's findings have potential implications for human spinal cord tissue engineering therapy.
Researchers have found that nasal drops of chemical compounds called polysulfides may prevent serious side effects of aortic surgery, such as paralysis of the lower body. In a mouse model of paraplegia after aortic surgery, intranasal administration of polysulfides inhibited damage to spinal cord motor neurons and prevented paraplegia.
Researchers found that spinal cord stimulation improved insomnia severity index and Epworth sleepiness scale scores by at least 30% in 39.1% and 28.1% of participants, respectively. The study also established minimally clinical important difference values to gauge treatment success.
A research team led by Dr. Eddie Ma Chi-him identified a therapeutic small molecule M1 that increases mitochondrial dynamics and sustains long-distance axon regeneration, restoring visual functions in mice. Regenerated axons elicited neural activities and survived for four weeks after optic nerve injury.
A new study has identified distinct patterns of circular RNA expression in human ALS muscle tissue, which display disease-specific gradients and could inform about neuromuscular molecular programs in ALS. The research reveals that specific circRNAs are elevated in ALS muscle biopsies but reduced in spinal cord samples from ALS patients.
Researchers found that dendritic cells in meninges produce mediators causing pain hypersensitivity after nerve injury. The kynurenine pathway, primarily driven by IDO1, is involved in pain production.
Scientists at Georgia Institute of Technology investigate how cats maintain balance while studying human spinal cord injury treatment.
Researchers at Florida Atlantic University's Schmidt College of Medicine have developed a handheld ultrasound device to treat neuropathic pain. The device uses low-intensity focused ultrasound to target specific areas of the nervous system, offering a non-invasive and non-opioid-based treatment option.
A Northwestern University study found that as people age, their cerebrospinal fluid immune system becomes dysregulated, leading to cognitive impairment and neurodegeneration. The discovery provides a new clue to the process of neurodegeneration and may potentially be used to treat inflammation of the brain.
Two studies by Harvard Medical School scientists show that the spinal cord and brainstem process touch information as it travels to higher-order brain regions. These findings highlight the importance of these areas in integrating and processing tactile stimuli.
A collaborative study reveals how genes controlling blood vessel cells influence motor neuron development, allowing them to navigate the body's systems. The discovery sheds light on diseases such as ALS and SMA, where motor neuron connections are destroyed.
Dr. Ted Price is leading a $11.3 million NIH multicenter project to elucidate the origins of pain, focusing on human nociceptor and spinal cord molecular signatures. Researchers will study DRG tissue from organ donors to understand how neurons communicate signals along the human pain pathway.
Researchers developed an epigenetic activator TTK21 to aid spinal cord regeneration in mice 12 weeks after severe injury. Treatment improved axon sprouting, sensory axon growth, and halted retraction of motor axons, leading to potential breakthroughs for human patients.
Stowers scientists investigate macrophage activation states in zebrafish sensory organ, discovering three distinct anti-inflammatory pathways that may inform human regenerative immunotherapies. The study provides valuable insights into the timing and genetic programs of macrophages, a type of white blood cell, in repair and regeneration.
A novel method developed by Brazilian researchers can analyze bacterial samples without isolating live bacteria, making it easier to detect antibiotic resistance in Streptococcus pneumoniae. The technique was tested on 873 samples and found that 51% were sensitive to antibiotics, while 17% were resistant.
Researchers are exploring the use of electrical spinal cord stimulation to help people with spinal cord injuries regain some movement. The study will investigate how the central nervous system changes in response to stimulation and exercise, with the goal of developing more effective rehabilitation strategies.
A novel stem cell-gene therapy has been shown to be safe in humans, with no serious side effects reported in the first trial. The treatment targets motor neurons that die in patients with amyotrophic lateral sclerosis (ALS), a fatal neurological disorder.
Researchers have identified a group of latent stem cells in the central nervous system of mice that respond to injury by dividing, migrating towards damaged areas, and differentiating into astrocytes. If similar cells exist in humans, they could provide a new therapeutic approach for treating spinal cord injuries.
Patients with long-term neuropathic pain took significantly fewer sick days after spinal cord stimulation treatment, indicating improved life quality. The study suggests that the treatment can increase life expectancy and reduce productivity loss for patients, resulting in cost savings for society.
Researchers developed nanometric photodiodes that can bind to nerve cell surfaces and activate them with infrared light, allowing for selective stimulation of individual neurons. This technology has the potential to study the nervous system in-depth and develop targeted therapies for neurological diseases.
A new gene therapy approach using the neuroprotective protein SynCav1 has shown promising results in slowing down ALS disease progression and increasing life span in rodent models. The treatment preserved spinal cord motor neurons and extended longevity in mice, with similar effects observed in a rat model of ALS.
Researchers have developed a new test that can detect even slightly elevated levels of tau protein in cerebrospinal fluid, potentially identifying Alzheimer’s disease at its earliest stages. The method uses optical sensors and 'lab-on-fiber' technology to achieve high sensitivity.
Researchers have discovered neural plastic changes that can improve functional recovery after a cervical spinal cord injury. Using an optogenetic neuromodulation strategy, they found that the intact corticospinal system in the opposite side of the brain and spinal cord can be modulated to take over control of the damaged forelimb, resu...
Researchers at Max Planck Institute for Intelligent Systems created a robot dog named Morti that can walk smoothly within an hour. The robot uses a Bayesian optimization algorithm to learn from sensor data and adapts its virtual spinal cord, allowing it to optimize its walking pattern and minimize stumbling.
A study published in PAIN Reports found that individuals with opioid use disorder (OUd) experience greater central sensitization, leading to worse quality of life. Central sensitization refers to abnormal pain processing in the brain and spinal cord, causing people to suffer more from pain.
Silvana Costa's research aims to identify cognitive dysfunction in acute traumatic spinal cord injury (tSCI) patients with co-occurring traumatic brain injury (TBI). The study uses eye movements as a biomarker to diagnose dual diagnosis, which affects 25-60% of the tSCI population.
Researchers developed a technology that uses surviving neurons to restore connection between brain and arm via specific stimulation pulses to the spinal cord. This allowed macaque monkeys with partial arm paralysis to improve precision, force, and range of movement in their arms.
A team of researchers identified a group of interneurons in the spinal cord required for heat sensation and found a signaling pathway that contributes to heat hypersensitivity. Their study may lead to more effective treatment for chronic, pathological pain.